Acute Myeloid Leukemia

Last Modified: 12/14/2021 6:57:57 AM


Medical Necessity Documentation:  
Client Notes:  
Patient Preparation:  
Specimen Requirements: 5.0 mL Whole Blood in an Lavender Top Tube
Collection Instructions: Requisition form and Pathology/Flow Cytometry Reports are required.
Minimum Volume: 2.0 mL Whole Blood
Transport & Storage: Temperature/Stability:

14 days Ambient
14 days Refrigerated
Unacceptable Frozen
Rejection Criteria: Gross hemolysis • Frozen • Clotted
Reference Range: Please refer to Interpretive Report
Critical Ranges:  
Test Comments:  
Methodology: Next Generation Sequencing • Long Range Polymerase Chain Reaction
Clinical Significance: This test is designed to aid in diagnosis and/or treatment strategy for patients with AML.
Documentation:  
Custom Panel: No

PRODUCTION SCHEDULE

Turn Around Time: 11 to 15 days
Days Performed: Tuesday, Thursday
Sites Performed: Quest - Chantilly to San Juan Capistrano
PHL Test Code: MSOT
EPIC Test Code: MISC
Send Out Test Code: 36787
Alternate Test Names: AML; LeukoVantage ®, Acute Myeloid Leukemia (AML); Myeloid NGS Panel AML
Included Tests:
ASXL1; ATM; BCOR; BCORL1; CBL; CDKN2B; CEBPA; CREBP(ATF2); CSF3R; DDX41; DNMT3A; ETV6; EZH2; FLT3; GATA1; GATA2; IDH1; IDH2; IKZF1; JAK2; KDM6A; KIT; KRAS; MLL (PTD only); MPL; NF1; NPM1; NRAS; PHF6; PTEN; PTPN11; RUNX1; SETBP1; SF3B1; SRSF2; STAG2; STK11; TET2; TP53; U2AF1; WT1; ZRSR2 genes
CPT Coding: 81450

Go back to the top of the page.